Oncogenic targeting of BRM drives malignancy through C/EBPß-dependent induction of a5 integrin.

Home / Publications / Oncogenic targeting of BRM drives malignancy through C/EBPß-dependent induction of a5 integrin.
Oncogene

Damiano L, Stewart KM, Cohet N, Mouw JK, Lakins JN, Debnath J, Reisman D, Nickerson JA, Imbalzano AN, Weaver VM. Oncogenic targeting of BRM drives malignancy through C/EBPß-dependent induction of a5 integrin. Oncogene. 2014 May 08; 33(19):2441-53.

2013
https://researcherprofiles.org/profile/1171155
23770848

Damiano L, Stewart KM, Cohet N, Mouw JK, Lakins JN, Debnath J, Reisman D, Nickerson JA, Imbalzano AN, Weaver VM

Support Engineering Innovations at UCSF

Donate